VREX - Varex Imaging Corp Stock Price, Fair Value and News

14.97USD-0.27 (-1.77%)Market Closed

Market Summary

USD14.97-0.27

Market Closed

-1.77%

VREX Alerts

Big fall in earnings (Y/Y)

VREX Stock Price

View Fullscreen

VREX RSI Chart

VREX Valuation

Market Cap

612.3M

Price/Earnings (Trailing)

14.61

Price/Sales (Trailing)

0.72

EV/EBITDA

13.1

Price/Free Cashflow

8.46

VREX Price/Sales (Trailing)

VREX Profitability

Operating Margin

32.71%

EBT Margin

2.31%

Return on Equity

7.1%

Return on Assets

3.35%

Free Cashflow Yield

11.82%

VREX Fundamentals

VREX Revenue

Revenue (TTM)

855.8M

Rev. Growth (Yr)

-9.64%

Rev. Growth (Qtr)

8.53%

VREX Earnings

Earnings (TTM)

41.9M

Earnings Growth (Yr)

-65.85%

Earnings Growth (Qtr)

380%

Breaking Down VREX Revenue

Last 7 days

-2.5%

Last 30 days

-11.5%

Last 90 days

-12.6%

Trailing 12 Months

-31.6%

How does VREX drawdown profile look like?

VREX Financial Health

Current Ratio

4.23

Debt/Equity

0.75

Debt/Cashflow

0.22

VREX Investor Care

Shares Dilution (1Y)

1.24%

Diluted EPS (TTM)

0.92

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	855.8M	0	0	0
2023	879.7M	897.4M	893.4M	877.8M
2022	851.0M	854.3M	859.4M	866.2M
2021	721.8M	761.8M	818.1M	839.8M
2020	796.2M	770.7M	738.3M	715.3M
2019	777.5M	783.0M	780.6M	795.0M
2018	763.3M	784.4M	773.4M	782.9M
2017	635.7M	654.4M	698.0M	716.9M
2016	626.2M	623.1M	620.1M	630.7M
2015	0	0	632.3M	629.3M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Varex Imaging Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 15, 2024	honeysett kimberley e.	sold	-49,678	17.37	-2,860	svp and clo
Feb 15, 2024	jonaitis mark s.	sold (taxes)	-41,951	17.4	-2,411	svp and gm, x-ray sources
Feb 15, 2024	jonaitis mark s.	acquired	-	-	4,890	svp and gm, x-ray sources
Feb 15, 2024	honeysett kimberley e.	sold (taxes)	-43,639	17.4	-2,508	svp and clo
Feb 15, 2024	honeysett kimberley e.	acquired	-	-	5,086	svp and clo
Feb 15, 2024	sanyal sunny	sold (taxes)	-235,248	17.4	-13,520	president and ceo
Feb 15, 2024	sanyal sunny	acquired	-	-	30,223	president and ceo
Feb 15, 2024	hartmann andrew	acquired	-	-	5,135	svp and gm, detectors
Feb 15, 2024	hartmann andrew	sold (taxes)	-42,264	17.4	-2,429	svp and gm, detectors
Feb 11, 2024	tsingos christine a	acquired	-	-	6,881	-

Which funds bought or sold VREX recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	JANE STREET GROUP, LLC	new	-	1,210,330	1,210,330	-%
May 16, 2024	HANCOCK WHITNEY CORP	new	-	295,647	295,647	0.01%
May 16, 2024	COMERICA BANK	added	98.12	291,401	680,313	-%
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-4.69	-137,707	731,186	-%
May 16, 2024	Ancora Advisors LLC	sold off	-100	-12,915	-	-%
May 15, 2024	TWO SIGMA INVESTMENTS, LP	reduced	-32.63	-4,147,930	6,088,600	0.01%
May 15, 2024	Petrus Trust Company, LTA	unchanged	-	-64,070	483,198	0.04%
May 15, 2024	MILLENNIUM MANAGEMENT LLC	reduced	-28.21	-6,435,110	11,139,500	-%
May 15, 2024	JANUS HENDERSON GROUP PLC	reduced	-96.2	-9,168,230	318,238	-%
May 15, 2024	CITADEL ADVISORS LLC	reduced	-38.85	-233,133	273,545	-%

Are Funds Buying or Selling VREX?

Are funds buying VREX calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own VREX

No. of Funds

VREX Alerts

Big fall in earnings (Y/Y)

Unveiling Varex Imaging Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	shapiro capital management llc	-	0	SC 13G
Feb 13, 2024	cooke & bieler lp	6.0%	2,432,583	SC 13G
Feb 13, 2024	vanguard group inc	11.31%	4,582,813	SC 13G/A
Feb 12, 2024	janus henderson group plc	1.1%	462,742	SC 13G/A
Feb 09, 2024	dimensional fund advisors lp	6.2%	2,519,686	SC 13G
Jan 23, 2024	state street corp	4.83%	1,956,381	SC 13G/A
Jan 19, 2024	blackrock inc.	19.0%	7,685,021	SC 13G/A
Jan 12, 2024	allspring global investments holdings, llc	7.49%	3,033,680	SC 13G/A
Feb 14, 2023	shapiro capital management llc	-	0	SC 13G
Feb 13, 2023	janus henderson group plc	5.1%	2,045,158	SC 13G

Recent SEC filings of Varex Imaging Corp

View All Filings

Date Filed	Form Type	Document
May 02, 2024	10-Q	Quarterly Report
May 02, 2024	8-K	Current Report
Mar 27, 2024	8-K	Current Report
Mar 19, 2024	4	Insider Trading
Mar 15, 2024	144	Notice of Insider Sale Intent
Feb 20, 2024	4	Insider Trading
Feb 20, 2024	4	Insider Trading
Feb 20, 2024	4	Insider Trading
Feb 20, 2024	4	Insider Trading
Feb 16, 2024	S-8	Employee Benefits Plan

Peers (Alternatives to Varex Imaging Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	181.0B	40.3B	-1.75%	-4.07%	32.18	4.49	-2.84%	-3.08%
BDX	68.3B	19.7B	1.78%	-6.05%	51.24	3.46	4.82%	-17.56%
ALGN	20.4B	3.9B	-9.57%	-7.50%	44.2	5.22	5.72%	46.72%
BAX	18.0B	14.9B	-10.73%	-18.01%	6.79	1.21	2.98%	207.68%
MID-CAP
ATR	9.8B	3.5B	6.68%	24.08%	31.27	2.76	6.16%	35.06%
HSIC	9.6B	12.5B	6.31%	-2.51%	24.63	0.77	-0.61%	-18.83%
BIO	8.4B	2.6B	1.13%	-22.65%	-26.02	3.22	-6.25%	-68.62%
XRAY	5.9B	3.9B	-6.79%	-30.12%	-62.84	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	0.52%	31.17%	-216.3	8.9	30.82%	65.57%
PDCO	2.3B	6.6B	0.19%	-5.50%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	5.94%	-10.00%	-1.91	0.41	7.94%	-1661.78%
ANIK	376.6M	169.3M	-1.13%	-2.23%	-4.9	2.23	7.49%	-244.90%
ANGO	241.9M	324.0M	-4.58%	-37.15%	-1.26	0.75	-3.19%	-337.41%
APYX	56.1M	50.5M	22.73%	-73.49%	-2.46	1.11	14.25%	-10.06%
AEMD	1.0M	3.7M	-71.83%	-87.10%	-0.09	0.28	5.77%	8.23%

Varex Imaging Corp News

Latest updates

Varex Imaging Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	8.5%	206	190	227	232	228	206	231	215	215	199	226	211	204	177	170	171	197	200	202	197	196
Gross Profit	15.2%	66.00	57.00	78.00	76.00	73.00	63.00	75.00	73.00	71.00	65.00	76.00	74.00	65.00	57.00	45.00	26.00	58.00	61.00	72.00	61.00	64.00
Operating Expenses	9.8%	58.00	53.00	54.00	52.00	57.00	50.00	50.00	50.00	44.00	51.00	49.00	48.00	49.00	51.00	58.00	53.00	56.00	57.00	55.00	56.00	50.00
S&GA Expenses	9.6%	36.00	32.00	32.00	32.00	34.00	30.00	30.00	30.00	25.00	33.00	31.00	29.00	31.00	34.00	41.00	31.00	35.00	35.00	36.00	31.00	30.00
R&D Expenses	10.2%	23.00	21.00	22.00	20.00	23.00	20.00	20.00	20.00	19.00	18.00	18.00	19.00	18.00	17.00	17.00	19.00	21.00	22.00	20.00	21.00	19.00
EBITDA Margin	-4.2%	0.08*	0.08*	0.09*	0.11*	0.11*	0.12*	0.12*	0.12*	0.13*	0.12*	0.11*	0.05*	-	-	-	-	-	-	-	-	-
Interest Expenses	8.2%	8.00	7.00	7.00	7.00	7.00	8.00	9.00	9.00	11.00	10.00	11.00	11.00	10.00	10.00	15.00	7.00	5.00	5.00	5.00	5.00	6.00
Income Taxes	450.0%	1.00	-0.20	-31.00	8.00	4.00	2.00	1.00	5.00	6.00	2.00	6.00	3.00	-	2.00	-4.30	-11.60	1.00	-	2.00	1.00	2.00
Earnings Before Taxes	483.3%	2.00	-0.60	1.00	17.00	8.00	5.00	14.00	14.00	14.00	3.00	15.00	15.00	3.00	-4.70	-	-39.80	-1.10	-1.20	10.00	-0.60	8.00
EBT Margin	-19.7%	0.02*	0.03*	0.04*	0.05*	0.05*	0.05*	0.05*	0.05*	0.06*	0.04*	0.03*	-0.03*	-	-	-	-	-	-	-	-	-
Net Income	380.0%	1.00	-0.50	32.00	9.00	4.00	3.00	13.00	8.00	8.00	1.00	9.00	12.00	3.00	-6.40	-26.40	-28.30	-1.90	-1.30	8.00	-1.40	6.00
Net Income Margin	-3.6%	0.05*	0.05*	0.05*	0.03*	0.03*	0.04*	0.04*	0.03*	0.03*	0.03*	0.02*	-0.02*	-	-	-	-	-	-	-	-	-
Free Cashflow	-2600.0%	-2.70	-0.10	42.00	34.00	22.00	-9.20	7.00	-6.70	-11.70	7.00	48.00	17.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	0.8%	1,252	1,242	1,250	1,212	1,191	1,181	1,184	1,163	1,143	1,139	1,148	1,161	1,133	1,137	1,140	1,122	1,082	1,068	1,039	1,044	966
Current Assets	1.0%	652	646	658	639	618	607	610	593	569	558	554	560	530	523	522	499	454	440	438	441	437
Cash Equivalents	1.3%	143	141	153	119	104	82.00	89.00	100	115	158	145	128	111	106	102	87.00	24.00	30.00	31.00	29.00	31.00
Inventory	-1.2%	286	290	278	298	311	320	303	300	269	248	225	243	248	270	272	283	282	269	248	263	261
Net PPE	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	146	-	142	139	137
Goodwill	-0.4%	289	290	289	289	289	288	285	287	290	291	292	294	293	295	293	291	291	291	291	290	244
Liabilities	0.3%	662	659	669	667	658	656	638	635	628	633	651	676	664	673	674	641	617	607	580	595	520
Current Liabilities	2.7%	154	150	163	159	157	157	173	172	167	150	167	186	146	153	161	192	198	191	175	171	156
Long Term Debt	0%	441	441	441	441	441	441	412	410	408	434	432	430	458	458	453	390	353	351	364	379	317
LT Debt, Current	-6.2%	2.00	2.00	2.00	2.00	2.00	2.00	2.00	3.00	3.00	3.00	3.00	33.00	3.00	3.00	3.00	28.00	30.00	30.00	31.00	30.00	29.00
LT Debt, Non Current	-100.0%	-	441	441	441	441	441	412	410	408	434	432	430	458	458	453	390	353	351	364	379	317
Shareholder's Equity	3.7%	590	569	568	532	533	525	547	528	514	506	497	485	469	464	466	470	454	451	448	438	435
Retained Earnings	1.3%	119	118	118	87.00	77.00	73.00	64.00	51.00	43.00	35.00	34.00	25.00	13.00	10.00	16.00	43.00	71.00	73.00	74.00	66.00	68.00
Additional Paid-In Capital	1.1%	458	453	450	445	442	438	469	465	460	458	449	446	441	439	434	427	380	378	372	368	363
Shares Outstanding	0.6%	41.00	41.00	41.00	40.00	40.00	40.00	40.00	40.00	40.00	40.00	39.00	39.00	-	-	-	-	-	-	-	-	-
Minority Interest	0%	14.00	14.00	13.00	13.00	13.00	13.00	13.00	13.00	13.00	13.00	13.00	13.00	14.00	14.00	14.00	3.00	3.00	3.00	3.00	3.00	2.00
Float	-	-	-	-	-	729	-	-	-	610	-	-	-	585	-	-	-	598	-	-	-	1,160

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-69.9%	3,100	10,300	47,100	37,700	27,300	-3,700	17,100	-2,700	-8,300	10,800	50,600	22,100	12,800	7,100	-11,800	1,100	900	23,000	22,900	16,100	12,900
Share Based Compensation	13.5%	4,200	3,700	3,400	3,600	3,200	3,300	3,300	3,400	3,900	3,400	3,300	3,400	3,600	3,600	3,200	3,700	3,300	3,200	3,000	3,100	3,000
Cashflow From Investing	93.5%	-1,300	-19,900	-14,600	-22,800	-3,800	-3,700	-27,500	-14,300	-4,000	-2,600	-3,300	-4,500	-4,000	-4,400	-3,700	-5,900	-6,700	-10,600	-6,800	-78,800	-4,200
Cashflow From Financing	23.5%	-1,300	-1,700	1,400	-700	-500	-400	200	1,400	-30,400	5,000	-31,000	-300	-3,200	2,200	26,900	68,800	-100	-12,000	-14,800	60,300	-32,500

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

VREX Income Statement

2024-03-29

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Mar. 29, 2024	Mar. 31, 2023	Mar. 29, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues, net	$ 206.2	$ 228.2	$ 396.2	$ 433.8
Cost of revenues	140.4	155.5	273.3	297.8
Gross profit	65.8	72.7	122.9	136.0
Operating expenses:
Research and development	22.6	23.0	43.1	43.0
Selling, general, and administrative	35.5	34.1	67.9	64.4
Total operating expenses	58.1	57.1	111.0	107.4
Operating income	7.7	15.6	11.9	28.6
Interest income	1.8	0.7	3.7	1.2
Interest expense	(7.9)	(7.3)	(15.2)	(14.8)
Other income (expense), net	0.7	(1.2)	1.3	(1.8)
Interest and other expense, net	(5.4)	(7.8)	(10.2)	(15.4)
Income before taxes	2.3	7.8	1.7	13.2
Income tax expense	0.7	3.5	0.5	5.7
Net income	1.6	4.3	1.2	7.5
Less: Net income attributable to noncontrolling interests	0.2	0.2	0.3	0.3
Net income attributable to Varex	$ 1.4	$ 4.1	$ 0.9	$ 7.2
Net income per common share attributable to Varex
Basic (in USD per share)	$ 0.03	$ 0.10	$ 0.02	$ 0.18
Diluted (in USD per share)	$ 0.03	$ 0.10	$ 0.02	$ 0.18
Weighted average common shares outstanding
Basic (in shares)	40.7	40.2	40.6	40.2
Diluted (in shares)	41.2	40.5	41.1	40.5

VREX Balance Sheet

2024-03-29

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($) $ in Millions	Mar. 29, 2024	Sep. 29, 2023
Current assets:
Cash and cash equivalents	$ 141.8	$ 152.6
Marketable securities	47.1	41.3
Accounts receivable, net of allowance for credit losses of $0.7 million and $0.6 million at March 29, 2024 and September 29, 2023, respectively	151.5	163.6
Inventories	286.1	277.5
Prepaid expenses and other current assets	25.4	23.3
Total current assets	651.9	658.3
Property, plant, and equipment, net	147.7	143.6
Goodwill	289.3	288.5
Intangible assets, net	18.2	22.4
Investments in privately-held companies	28.9	29.0
Deferred tax assets	47.8	41.3
Operating lease assets	29.5	29.0
Other assets	38.4	37.5
Total assets	1,251.7	1,249.6
Current liabilities:
Accounts payable	69.4	64.7
Accrued liabilities and other current liabilities	69.4	82.6
Current operating lease liabilities	3.8	3.8
Current maturities of long-term debt	1.5	1.5
Deferred revenues	10.0	10.2
Total current liabilities	154.1	162.8
Long-term debt, net	441.4	441.1
Operating lease liabilities	23.9	23.1
Other long-term liabilities	42.1	41.6
Total liabilities	661.5	668.6
Stockholders' equity:
Preferred stock, $.01 par value: 20,000,000 shares authorized, none issued	0.0	0.0
Common stock, $.01 par value: 150,000,000 shares authorized Shares issued and outstanding: TBU and 40,529,573 at March 29, 2024 and September 29, 2023, respectively	0.4	0.4
Additional paid-in capital	458.4	450.4
Accumulated other comprehensive loss	(1.7)	(1.2)
Retained earnings	119.0	118.1
Total Varex stockholders' equity	576.1	567.7
Noncontrolling interests	14.1	13.3
Total stockholders' equity	590.2	581.0
Total liabilities and stockholders' equity	$ 1,251.7	$ 1,249.6

About Varex Imaging Corp

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was incorporated in 2016 and is headquartered in Salt Lake City, Utah.

CEO	Mr. Sunny S. Sanyal
WEBSITE	vareximaging.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	2300

Varex Imaging Corp Frequently Asked Questions

What is the ticker symbol for Varex Imaging Corp? What does VREX stand for in stocks?

VREX is the stock ticker symbol of Varex Imaging Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Varex Imaging Corp (VREX)?

As of Fri May 17 2024, market cap of Varex Imaging Corp is 612.27 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of VREX stock?

You can check VREX's fair value in chart for subscribers.

What is the fair value of VREX stock?

You can check VREX's fair value in chart for subscribers. The fair value of Varex Imaging Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Varex Imaging Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for VREX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Varex Imaging Corp a good stock to buy?

The fair value guage provides a quick view whether VREX is over valued or under valued. Whether Varex Imaging Corp is cheap or expensive depends on the assumptions which impact Varex Imaging Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VREX.

What is Varex Imaging Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, VREX's PE ratio (Price to Earnings) is 14.61 and Price to Sales (PS) ratio is 0.72. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. VREX PE ratio will change depending on the future growth rate expectations of investors.